| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1006036-87-8 | MK-2894;4-(1-(((2,5-Dimethyl-4-((4-(trifluoromethyl)phenyl)methyl)-3-thienyl)carbonyl)amino)cyclopropyl)benzoic acid | C25H22F3NO3S |
| 1006036-88-9 | MK-2894 Na salt;4-(1-(((2,5-Dimethyl-4-((4-(trifluoromethyl)phenyl)methyl)-3-thienyl)carbonyl)amino)cyclopropyl)benzoic acid sodium salt | C25H22F3NO3S.Na |
| 1006062-27-6 | O-Acetyl losartan;2-Butyl-4-chloro-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol 5-acetate | C24H25ClN6O2 |
| 1006335-39-2 | N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-4,5-dihydro-5-isoxazolecarboxamide;ISPA 28 | C21H24N6O3 |
| 1006376-60-8 | (alphaS)-alpha-(Chloromethyl)-3,4-difluorobenzenemethanol | C8H7ClF2O |
| 1006376-61-9 | (1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxylic acid ethyl ester | C12H12F2O2 |
| 1006376-62-0 | (1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxamide | C10H9F2NO |
| 1006378-06-8 | Gefitinib Impurity 17;4-Methoxy-3-(3-morpholinopropoxy)-2-nitrobenzonitrile | C15H19N3O5 |
| 1006381-03-8 | (4R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide;(R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide | C3H6O4S |
| 1006436-44-7 | 1-Methyl-3-(trifluoromethyl)-1H-pyrazol-4-amine | C5H6F3N3 |
| 1006614-49-8 | (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine | C9H9F2N |
| 1006876-27-2 | N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide | C14H21BN2O3 |
| 1006891-07-1 | 7-Methoxy-3-methyl-6-(2-(quinolin-2-yl)ethoxy)quinazolin-4(3H)-one | C21H19N3O3 |
| 1007089-84-0 | 3-(Chloromethyl)-5-methylpyridine hydrochloride | C7H7N.HCl |
| 1007206-54-3 | 1H-Benzimidazole-5-boronic acid pinacol ester;5-(4,4,5,5-Tetramethyl-(1,3,2)dioxaborolan-2-yl)-1H-benzimidazole; 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-benzo(d)imidazole | C13H17BN2O2 |
| 1007207-67-1 | (5-(7-Methylsulfonyl-2-(morpholin-4-yl)-6,7-dihydro-5H-pyrrolo(2,3-d)pyrimidin-4-yl)pyrimidin-2-yl)amine | C15H19N7O3S |
| 1007207-89-7 | (3-Bromo-4-fluorophenyl)(morpholin-4-yl)methanone | C11H11BrFNO2 |
| 1007219-73-9 | 1-Methyl-1H-indazole-6-carboxylic acid methyl ester | C10H10N2O2 |
| 1007308-74-8 | 7-Fluoro-6-nitro-2,4(1H,3H)-quinazolinedione | C8H4FN3O4 |
| 1007308-75-9 | 2,4-Dichloro-7-fluoro-6-nitroquinazoline | C8H2Cl2FN3O2 |
| 1007311-95-6 | Dicyclohexyl(9-(3-phenylpropyl)-9H-fluoren-9-yl)phosphine tetrafluoroborate | C34H41P.BF4.H |
| 1007311-98-9 | (9-Butyl-9H-fluoren-9-yl)dicyclohexylphosphine tetrafluoroborate | C29H39P.BF4.H |
| 1007358-76-0 | (R)-Ambrisentan;(2R)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid | C22H22N2O4 |
| 1007455-21-1 | 2-Bromo-4-fluoro-5-methoxybenzoic acid | C8H6BrFO3 |
| 1007455-25-5 | 5-Fluoro-2,3-dihydro-6-hydroxy-1H-isoindol-1-one;5-Fluoro-6-hydroxy-2,3-dihydroisoindol-1-one | C8H6FNO2 |
| 1007455-28-8 | 6-Bromo-2-fluoro-3-methoxybenzoic acid methyl ester | C9H8BrFO3 |
| 1007459-98-4 | N-(Methyl-d3)carbamic acid 2,3-dihydro-2,2-dimethyl-7-benzofuranyl ester | C12H12D3NO3 |
| 1007462-48-7 | 2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)ethanol | C8H14N2O |
| 1007468-17-8 | 3-(difluoromethyl)-1H-pyrazole;5-(difluoromethyl)-1H-pyrazole | C4H4F2N2 |
| 1007476-86-9 | 1-(2-Nitrobenzylidenamino)-2,4-imidazolidinedione-(2,4,5-13C) | C10H8N4O4 |
| 1007478-57-0 | 3-((E)-(2-Nitrobenzylidene)amino)(d4)-1,3-oxazolidin-2-one;2-NP-AOZ-d4 | C10H5D4N3O4 |
| 1007536-67-5 | N'-(3,4-Dichlorophenyl)-N,N-di(methyl-d3)urea | C9H4Cl2D6N2O |
| 1007572-07-7 | 2-(4-Bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl)acetic acid | C15H8BrClFNO3 |
| 1007596-95-3 | trans-4-Amino-1-boc-3-hydroxypiperidine | C10H20N2O3 |
| 1007605-44-8 | 2,5-Difluoro-4-methoxybenzonitrile | C8H5F2NO |
| 1007840-62-1 | N-((9H-Fluoren-9-ylmethoxy)carbonyl)-S-(triphenylmethyl)-D-homocysteine | C38H33NO4S |
| 1007881-21-1 | N-(Methoxycarbonyl)-O-methyl-L-threonine;(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoic acid | C7H13NO5 |
| 1007882-04-3 | tert-Butyl (S)-2-(5-(4-bromophenyl)-1H-imidazol-2-yl)pyrrolidine-1-carboxylate | C18H22BrN3O2 |
| 1007882-23-6 | (2S,2'S)-2,2'-((1,1'-Biphenyl)-4,4'-diyldi-1H-imidazole-5,2-diyl)bis-1-pyrrolidinecarboxylic acid 1,1'-bis(1,1-dimethylethyl) ester | C36H44N6O4 |
| 1007882-58-7 | tert-Butyl (S)-2-(1H-imidazol-2-yl)pyrrolidine-1-carboxylate;tert-Butyl (2S)-2-(1H-imidazol-2-yl)pyrrolidine-1-carboxylate | C12H19N3O2 |
| 1007882-59-8 | tert-Butyl (S)-2-(4-bromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate;(S)-tert-Butyl 2-(5-bromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate | C12H18BrN3O2 |
| 1008105-17-6 | Formamidinium tribromoplumbate | CH4N2.PbBr3.H |
| 1008106-86-2 | 2-Iodophenylboronic acid | C6H6BIO2 |
| 1008106-93-1 | B-(2,5-Dibromophenyl)boronic acid | C6H5BBr2O2 |
| 1008112-09-1 | (3S,4R)-4-Phenylpyrrolidin-3-ol hydrochloride | C10H13NO |
| 1008119-83-2 | JM 6;JM 6 (enzyme inhibitor); 3,4-Dimethoxy-N-(4-(3-nitrophenyl)-5-(1-piperidinylmethyl)-2-thiazolyl)benzenesulfonamide | C23H26N4O6S2 |
| 1008138-73-5 | Ethyl 5-amino-6-methylpyridine-3-carboxylate | C9H12N2O2 |
| 1008139-25-0 | Isoxazol-4-ylboronic acid | C3H4BNO3 |
| 1008361-72-5 | 5-bromo-4-fluoro-1H-benzimidazole | C7H4BrFN2 |
| 1008361-77-0 | 3-Bromo-6-iodo-2-methylpyridine | C6H5BrIN |